RhoH aSHM was found to contribute to cancer progression from FL or chronic lymphocytic leukaemia (CLL) to DLBCL, indicating that deregulation of RhoH protein expression is highly related to higher-grade lymphomas and might act as an important prognostic marker [43,44]. Here, RHOH is linked to diffuse large B-cell lymphoma.